Kathleen Tregoning - Insider Trading & Ownership

Entity
Individual
Location
C/O Cerevel Therapeutics Holdings, Inc., 131 Dartmouth Street Suite 502, Boston, MA
Summary
The estimated net worth of Kathleen Tregoning is at least $120K dollars as of August 5, 2024. Kathleen Tregoning is the Director of Spero Therapeutics, Inc. and owns shares of Spero Therapeutics, Inc. (SPRO) stock worth about $120K.
All Insider Reports
All Insider Reports

Ownership of Kathleen Tregoning

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SPRO Spero Therapeutics, Inc. Director $120K May 29, 2024
CERE Cerevel Therapeutics Holdings, Inc. Chief Corporate Affairs Officer $0 -$260K -100% Aug 1, 2024

Insider Transactions Reported by Kathleen Tregoning:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.